Long-term results of topical 0.02% tacrolimus ointment for refractory ocular surface inflammation in pediatric patients

BACKGROUND: No studies have been reported on the efficacy and safety of long-term (≥12 months) use of topical tacrolimus for refractory ocular surface inflammation in pediatric patients. METHODS: Medical records of pediatric patients who were prescribed topical 0.02% tacrolimus ointment for refracto...

Descripción completa

Detalles Bibliográficos
Autores principales: Koh, Kyungmin, Jun, Ikhyun, Kim, Tae-im, Kim, Eung Kweon, Seo, Kyoung Yul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178927/
https://www.ncbi.nlm.nih.gov/pubmed/34088281
http://dx.doi.org/10.1186/s12886-021-01998-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178927/
https://www.ncbi.nlm.nih.gov/pubmed/34088281
http://dx.doi.org/10.1186/s12886-021-01998-0

Ejemplares similares